These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
442 related items for PubMed ID: 25470765
1. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms. Lesesve JF, Tardy S, Frotscher B, Latger-Cannard V, Feugier P, De Carvalho Bittencourt M. Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765 [Abstract] [Full Text] [Related]
2. Differential and tumor-specific expression of CD160 in B-cell malignancies. Farren TW, Giustiniani J, Liu FT, Tsitsikas DA, Macey MG, Cavenagh JD, Oakervee HE, Taussig D, Newland AC, Calaminici M, Bensussan A, Jenner M, Gribben JG, Agrawal SG. Blood; 2011 Aug 25; 118(8):2174-83. PubMed ID: 21715317 [Abstract] [Full Text] [Related]
3. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly. Sreedharanunni S, Sachdeva MU, Malhotra P, Ahluwalia J, Naseem S, Prakash G, Khadwal A, Sharma P, Kumar N, Varma N, Varma S, Das R. Hematology; 2015 Oct 25; 20(9):530-7. PubMed ID: 25760312 [Abstract] [Full Text] [Related]
4. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Sandes AF, de Lourdes Chauffaille M, Oliveira CR, Maekawa Y, Tamashiro N, Takao TT, Ritter EC, Rizzatti EG. Cytometry B Clin Cytom; 2014 Mar 25; 86(2):98-105. PubMed ID: 24243815 [Abstract] [Full Text] [Related]
5. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Sánchez ML, Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A. Leukemia; 2002 Aug 25; 16(8):1460-9. PubMed ID: 12145686 [Abstract] [Full Text] [Related]
11. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. Leukemia; 1994 Oct 25; 8(10):1640-5. PubMed ID: 7523797 [Abstract] [Full Text] [Related]
18. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping. Hoffmann J, Rother M, Kaiser U, Thrun MC, Wilhelm C, Gruen A, Niebergall U, Meissauer U, Neubauer A, Brendel C. Cytometry B Clin Cytom; 2020 Nov 25; 98(6):476-482. PubMed ID: 32716606 [Abstract] [Full Text] [Related]
19. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology]. El Borgi W, Ben Salah N, Ben Lakhal F, Makni L, Gouider E, Hafsia R. Ann Biol Clin (Paris); 2013 Nov 25; 71(6):693-7. PubMed ID: 24342790 [Abstract] [Full Text] [Related]
20. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders. Pillai V, Pozdnyakova O, Charest K, Li B, Shahsafaei A, Dorfman DM. Am J Clin Pathol; 2013 Oct 25; 140(4):536-43. PubMed ID: 24045551 [Abstract] [Full Text] [Related] Page: [Next] [New Search]